Fire needle plus cupping on pain improvement in patients with herpes zoster:a randomized controlled trial

Not Applicable

• Conditions: Herpes zoster

• Registration Number: ITMCTR2100005390
• Lead Sponsor: Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

? Older than 18 years old;
? Meet the diagnostic criteria of herpes zoster in the consensus of Chinese experts on herpes zoster in 2018;
? Within 6 days after herpes zoster eruption;
? The average value of maximum pain per day after rash was vas = 3;
? The patient signed the informed consent form and voluntarily participated in the trial.

Exclusion Criteria

? It is complicated with serious primary diseases such as cardio cerebrovascular, liver, kidney and hematopoietic system, as well as other organic diseases such as tumors;
? Patients with depression, anxiety and other mental disorders who need to take tricyclic antidepressants, and mental or intellectual disorders who cannot cooperate with the questionnaire;
? Patients with bleeding tendency, pain related skin diseases or scar constitution;
? Pregnant and lactating women, who have fertility requirements in recent half a year;
? Known immune deficiency status or history of HIV infection, hepatitis B antigen or hepatitis C antibody positive history, active tuberculosis or 1 months of use of corticosteroids or immunosuppressants;
? Poor blood glucose control, glycosylated hemoglobin = 8.0%;
? Patients with coagulation dysfunction or taking antiplatelet and anticoagulant drugs;
? Received acupuncture treatment in recent 1 week;
? It belongs to the special type of herpes zoster: eye and ear herpes zoster, contusive herpes zoster, non eruptive herpes zoster, herpes zoster meningitis or encephalitis, herpes zoster invading visceral nerve fibers, disseminated herpes zoster and others (herpes zoster with bullous, hemorrhagic, gangrenous and other manifestations);
? Those who are participating in other clinical trials.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
VAS responder rate(=30%);